Detalhe da pesquisa
1.
SARS-CoV-2 infection and vaccination in patients with hairy-cell leukaemia.
Br J Haematol
; 201(3): 411-416, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36541031
2.
High rate of durable responses with undetectable minimal residual disease with front-line venetoclax and rituximab in young, fit patients with chronic lymphocytic leukemia and an adverse biological profile: results of the GIMEMA phase II LLC1518 - VERITAS study.
Haematologica
; 108(8): 2091-2100, 2023 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36632738
3.
Impact of immunochemotherapy with R-bendamustine or R-CHOP for treatment naïve advanced-stage follicular lymphoma: A subset analysis of the FOLL12 trial by Fondazione Italiana Linfomi.
Hematol Oncol
; 41(4): 655-662, 2023 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-37246287
4.
SARS-CoV-2 infection in patients with chronic lymphocytic leukemia: The Italian Hematology Alliance on COVID-19 cohort.
Hematol Oncol
; 41(1): 128-138, 2023 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-36265128
5.
Mitochondrial metabolism: Inducer or therapeutic target in tumor immune-resistance?
Semin Cell Dev Biol
; 98: 80-89, 2020 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-31100351
6.
Lack of efficacy of convalescent plasma in COVID-19 patients with concomitant hematological malignancies: An Italian retrospective study.
Hematol Oncol
; 40(5): 857-863, 2022 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-35932208
7.
Secondary infections worsen the outcome of COVID-19 in patients with hematological malignancies: A report from the ITA-HEMA-COV.
Hematol Oncol
; 40(5): 846-856, 2022 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-35854643
8.
Molecular dynamics of targeting CD38 in multiple myeloma.
Br J Haematol
; 193(3): 581-591, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33570193
9.
COVID-19 elicits an impaired antibody response against SARS-CoV-2 in patients with haematological malignancies.
Br J Haematol
; 195(3): 371-377, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34272724
10.
Atypical Chronic Myeloid Leukemia: New Developments from Molecular Diagnosis to Treatment.
Medicina (Kaunas)
; 57(10)2021 Oct 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-34684141
11.
HIF-1α is over-expressed in leukemic cells from TP53-disrupted patients and is a promising therapeutic target in chronic lymphocytic leukemia.
Haematologica
; 105(4): 1042-1054, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-31289209
12.
A Position Paper on IgM-Enriched Intravenous Immunoglobulin Adjunctive Therapy in Severe Acute Bacterial Infections: The TO-PIRO SCORE Proposal.
New Microbiol
; 42(3): 176-180, 2019 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-31157400
13.
Practical management of ibrutinib in the real life: Focus on atrial fibrillation and bleeding.
Hematol Oncol
; 36(4): 624-632, 2018 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-29512173
14.
Induction of robust humoral immunity against SARS-CoV-2 after vaccine administration in previously infected haematological cancer patients.
Br J Haematol
; 199(3): 463-467, 2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-36062472
15.
Molecular prediction of durable remission after first-line fludarabine-cyclophosphamide-rituximab in chronic lymphocytic leukemia.
Blood
; 126(16): 1921-4, 2015 Oct 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-26276669
16.
Immunomodulatory and clinical effects of daratumumab in T-cell acute lymphoblastic leukaemia.
Br J Haematol
; 191(1): e28-e32, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32686081
17.
Chicago 2014--30 years of γδ T cells.
Cell Immunol
; 296(1): 3-9, 2015 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-25468804
18.
Dysfunctional Vγ9Vδ2 T cells are negative prognosticators and markers of dysregulated mevalonate pathway activity in chronic lymphocytic leukemia cells.
Blood
; 120(16): 3271-9, 2012 Oct 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-22932792
19.
The bone marrow of myeloma patients is steadily inhabited by a normal-sized pool of functional regulatory T cells irrespectiveof the disease status.
Haematologica
; 99(10): 1605-10, 2014 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-24972771
20.
Chlorambucil plus rituximab with or without maintenance rituximab as first-line treatment for elderly chronic lymphocytic leukemia patients.
Am J Hematol
; 89(5): 480-6, 2014 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-24415640